Commonwealth Equity Services, LLC Seelos Therapeutics, Inc. Transaction History

Commonwealth Equity Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$0.16 - $1.64 $207 - $2,130	1,299 Added 4.88%	27,942 $5,000
Q2 2023 Aug 10, 2023	SELL	$0.66 - $1.22 $1,692 - $3,128	-2,564 Reduced 8.78%	26,643 $32,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $1.41 $1,495 - $3,243	2,300 Added 8.55%	29,207 $30,000
Q1 2022 May 04, 2022	BUY	$0.84 - $1.71 $458 - $933	546 Added 2.07%	26,907 $22,000
Q4 2021 Jan 31, 2022	BUY	$1.59 - $2.38 $3,180 - $4,760	2,000 Added 8.21%	26,361 $42,000

Q3 2021 Oct 29, 2021	BUY	$1.69 - $2.89 $7,910 - $13,528	4,681 Added 23.79%	24,361 $58,000
Q2 2021 Aug 11, 2021	BUY	$2.64 - $6.32 $2,798 - $6,699	1,060 Added 5.69%	19,680 $51,000
Q1 2021 May 04, 2021	BUY	$1.35 - $4.99 $25,137 - $92,913	18,620 New	18,620 $92,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $59.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.